| 摘要 |
PCT No. PCT/JP96/01069 Sec. 371 Date Oct. 20, 1997 Sec. 102(e) Date Oct. 20, 1997 PCT Filed Apr. 19, 1996 PCT Pub. No. WO96/32945 PCT Pub. Date Oct. 24, 1996The invention relates to a neovascularization inhibitor composition comprising a compound of the following general formula [I] or a salt thereof, or a solvate thereof, as an active ingredient, wherein R1 represents hydrogen, optionally substituted alkyl, aralkyl, arylalkenyl, or aryl; R2 represents optionally substituted alkyl, aralkyl, arylalkenyl, or aryl; or R1 and R2 conjoinedly and taken together with the adjacent N atom, i.e. in the form of NR1R2, represent a 4- through 8-membered cyclic amino group optionally containing nitrogen, oxygen, or sulfur as a ring member in addition to said N atom and optionally being further substituted.
|
